MediFind
Condition

Transthyretin Amyloidosis

Symptoms, Doctors, Treatments, Research & More

Latest Research

Latest Advance
Study
  • Condition: Cardiac Amyloidosis (CA)
  • Journal: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
  • Treatment Used: Implantable Cardioverter-Defibrillator (ICD)
  • Number of Patients: 91
  • Published —
This study assessed survival in patients with cardiac amyloidosis (stiff heart; CA) with and without a primary prevention implantable cardioverter-defibrillator (ICD).
Latest Advance
Study
  • Condition: Hereditary Transthyretin Amyloidosis
  • Journal: European journal of neurology
  • Treatment Used: Inotersen
  • Number of Patients: 139
  • Published —
The study researched the safety and effectiveness of inotersen in patients with hereditary transthyretin amyloidosis.
Latest Advance
Study
  • Condition: Amyloid Cardiomyopathy
  • Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
  • Treatment Used: Inotersen
  • Number of Patients: 33
  • Published —
In this study, researchers evaluated the effects of using inotersen for the treatment of amyloid cardiomyopathy.
Latest Advance
Study
  • Condition: Hereditary transthyretin-mediated amyloidosis
  • Journal: Molecular diagnosis & therapy
  • Treatment Used: Patisiran
  • Number of Patients: 0
  • Published —
The study researched the effects of Patisiran on hereditary transthyretin-mediated amyloidosis.
Latest Advance
Study
  • Condition: Autosomal Dominant Hereditary Transthyretin (TTR) Amyloidosis (ATTR)
  • Journal: Deutsche medizinische Wochenschrift (1946)
  • Treatment Used: Liver Transplantation (LTx), Diflunisal, Tafamidis, Inotersen, Patisiran
  • Number of Patients: 0
  • Published —
This article discusses the rare, progressive, and fatal disease, autosomal dominant hereditary transthyretin (TTR) amyloidosis (ATTR) and its treatment with liver transplantation (LTx) and gene silencers.
Latest Advance
Study
  • Condition: Severe Heart Failure Due to Transthyretin Amyloid Cardiomyopathy
  • Journal: Internal medicine (Tokyo, Japan)
  • Treatment Used: Pimobendan
  • Number of Patients: 1
  • Published —
In this case study, researchers evaluated the effects of pimobendan on severe heart failure due to transthyretin amyloid cardiomyopathy.
Latest Advance
Study
  • Condition: Transthyretin Amyloidosis
  • Journal: Journal of cardiovascular electrophysiology
  • Treatment Used: Cardiac Devices
  • Number of Patients: 78
  • Published —
The purpose of this study was to evaluate the effectiveness of cardiac devices in patients with transthyretin amyloidosis (i.e. it is a genetic disease caused in a mutation in the transthyretin gene that causes protein deposits in organs and tissues).
Latest Advance
Study
  • Condition: Orthostatic Hypotension
  • Journal: Clinical autonomic research : official journal of the Clinical Autonomic Research Society
  • Treatment Used: Droxidopa
  • Number of Patients: 0
  • Published —
In this study, researchers evaluated the effectiveness of droxidopa when used for orthostatic hypotension due to hereditary transthyretin amyloidosis.
Latest Advance
Study
  • Condition: Autonomic neuropathy in hereditary transthyretin (ATTR) amyloidosis
  • Journal: Clinical autonomic research : official journal of the Clinical Autonomic Research Society
  • Treatment Used: Tafamidis
  • Number of Patients: 0
  • Published —
The study researched the use of Tafamidis for treating autonomic neuropathy in hereditary transthyretin (ATTR) amyloidosis.
Latest Advance
Study
  • Condition: Hereditary transthyretin amyloidosis
  • Journal: Brain and behavior
  • Treatment Used: Inotersen and patisiran
  • Number of Patients: 0
  • Published —
The study researched treatment methods for hereditary transthyretin amyloidosis.
Latest Advance
Study
  • Condition: Transthyretin Amyloid Polyneuropathy (ATTR-PN)
  • Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
  • Treatment Used: Tafamidis
  • Number of Patients: 137
  • Published —
This study evaluated the safety of tafamidis in patients with transthyretin amyloid polyneuropathy (buildup of abnormal deposits of a protein called amyloid - amyloidosis - in the body's organs and tissues; ATTR-PN).